GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Acadia Pharmaceuticals Inc. (ACAD) [hlAlert]

Rating:
Buy ACAD
up 15.36 %

Acadia Pharmaceuticals Inc. (ACAD) rated Buy with price target $42 by ROTH Capital

Posted on: Friday,  Feb 6, 2015  8:25 AM ET by Roth Capital

Roth Capital rated Buy Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) on 02/06/2015, when the stock price was $32.86. Since
then, Acadia Pharmaceuticals Inc. has gained 15.37% as of 01/25/2016's recent price of $37.91.
If you would have followed this Roth Capital's recommendation on ACAD, you would have gained 15.36% of your investment in 353 days.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company is developing a portfolio consisting of its four product candidates, including pimavanserin, which is in Phase III development for the treatment of Parkinson?s disease psychosis. In addition, the Company has a product candidate in Phase II for chronic pain and a product candidate in Phase I for glaucoma, both in collaboration with Allergan, Inc., and ACP-106 in IND-track development. The Company?s product candidates include Pimavanserin, AGN-XX/YY, AC-262271 and ACP-106. The Company maintains two wholly owned subsidiaries: ACADIA Pharmaceuticals AB based in Malmo, Sweden and ACADIA Pharmaceuticals A/S based in Denmark.

ROTH researches emerging growth equities in the media, technology, telecommunications, healthcare, consumer, energy and industrial sectors. The research is focused on companies with market capitalization of between $100 million - $1 billion. Our coverage universe includes approximately 180 small cap growth companies around the globe including several companies from China. With an average market cap of approximately $500 million, our objective is to identify rapidly growing companies with significant long term growth prospects.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/6/2015 8:25 AM Buy
None
32.86 42.00
as of 8/27/2015
1 Week down  -3.14 %
1 Month down  -11.67 %
3 Months down  -2.91 %
1 YTD up  15.36 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy